rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2000-7-14
|
pubmed:abstractText |
Transplantation of fetal cardiomyocytes improves function of infarcted myocardium but raises availability, immunologic, and ethical issues that justify the investigation of alternate cell types, among which skeletal myoblasts are attractive candidates.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-5223
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1169-75
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10838534-Animals,
pubmed-meshheading:10838534-Cell Transplantation,
pubmed-meshheading:10838534-Heart,
pubmed-meshheading:10838534-Muscle, Skeletal,
pubmed-meshheading:10838534-Myocardial Infarction,
pubmed-meshheading:10838534-Myocardium,
pubmed-meshheading:10838534-Rats,
pubmed-meshheading:10838534-Rats, Wistar,
pubmed-meshheading:10838534-Ventricular Function, Left
|
pubmed:year |
2000
|
pubmed:articleTitle |
Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function.
|
pubmed:affiliation |
Department of Cardiovascular Surgery, Hôpital Bichat, INSERM U-127, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|